Related references
Note: Only part of the references are listed.Treatment Guidelines for Rheumatologic Manifestations of Sjogren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain
Steven E. Carsons et al.
ARTHRITIS CARE & RESEARCH (2017)
Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis
Shi-Qin Wang et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjogren's syndrome: a pilot study
N. Yokoi et al.
EYE (2016)
Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjogren's Syndrome: A Double-Blind Randomized Control Study
Chang Ho Yoon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Rituximab Effectiveness and Safety for Treating Primary Sjogren's Syndrome (pSS): Systematic Review and Meta-Analysis
Francine Bertolais do Valle Souza et al.
PLOS ONE (2016)
New Treatment Guidelines for Sjogren's Diseasee
Frederick B. Vivino et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Comparative Evaluation of Silicone Hydrogel Contact Lenses and Autologous Serum for Management of Sjogren Syndrome-Associated Dry Eye
Jinyang Li et al.
CORNEA (2015)
Autologous Serum Eye Drops for the Treatment of Ocular Surface Disease
Amir A. Azari et al.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2015)
Topical Fluorometholone Treatment for Ocular Dryness in Patients With Sjogren Syndrome A Randomized Clinical Trial in China
Tong Lin et al.
MEDICINE (2015)
Treatment of Sjogren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study
Bernardo Kaplan Moscovici et al.
CONTACT LENS & ANTERIOR EYE (2015)
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis
Baodong Qin et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjogren's Syndrome
Sarah Brown et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial
Jacques-Eric Gottenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome
Pasquale Aragona et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Punctal plugs versus artificial tears for treating primary Sjogren's syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function
Weiqiang Qiu et al.
RHEUMATOLOGY INTERNATIONAL (2013)
American College of Rheumatology classification criteria for Sjogren's syndrome: A data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance Cohort
S. C. Shiboski et al.
ARTHRITIS CARE & RESEARCH (2012)
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Role of lactoferrin in the tear film
J. L. Flanagan et al.
BIOCHIMIE (2009)
Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren's Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations
Helena Forsblad-d'Elia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis sicca caused by Sjogren syndrome - A uniocular evaluation
Khaled Mansour et al.
CORNEA (2007)
Systemic omega-6 essential fatty acid treatment and PGE1 tear content in Sjogren's syndrome patients
P Aragona et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients
P Aragona et al.
EYE (2005)
Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's Syndrome
SR Pillemer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Etanercept in Sjogren's syndrome - A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
V Sankar et al.
ARTHRITIS AND RHEUMATISM (2004)
Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: A randomized, double-blind clinical study
M Ono et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome
J Hulkkonen et al.
RHEUMATOLOGY (2004)
Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease
BA Noble et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren's syndrome: a randomised 12 week controlled study
N Tsifetaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca
D Petrone et al.
ARTHRITIS AND RHEUMATISM (2002)
Polyunsaturated fatty acids and rheumatoid arthritis
PC Calder et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates
W Pendergast et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
The effects of the topical administration of non-steroidal antiinflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects
P Aragona et al.
EYE (2000)